| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780840 | Gynecologic Oncology | 2017 | 7 Pages |
Abstract
This study confirms the activity and safety of single-agent EP in patients with PROC, including patients who received prior PLD. Further evaluation earlier in the disease course and in combination is warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
G. Rustin, I. Vergote, J.P. Micha, L.R. Duska, N. Reed, J. Bendell, D. Spitz, G. Dark, U. Hoch, M. Tagliaferri, A.L. Hannah, A.A. Garcia,